Skip to main content
. 2017 Nov 27;52(2):424–432. doi: 10.3892/ijo.2017.4212

Table III.

Prognostic value of p-STAT3 (immunohistochemistry) using univariate analysis.

DFS
OS
HR (95% CI) P-value HR (95% CI) P-value
All
 Tumour p-STAT3 ordinala 0.84 (0.68–1.04) 0.10 0.83 (0.63–1.08) 0.16
 Tumour p-STAT3 binary (positive vs. negative) 0.72 (0.51–1.04) 0.08 0.75 (0.48–1.18) 0.21
 Stroma p-STAT3 ordinala 0.85 (0.68–1.05) 0.13 0.88 (0.67–1.15) 0.34
 Stroma p-STAT3 binary (positive vs. negative) 0.78 (0.55–1.08) 0.14 0.79 (0.52–1.21) 0.28
ER+/HER2−
 Tumour p-STAT3 ordinala 0.80 (0.63–1.01) 0.06 0.83 (0.62–1.11) 0.22
 Tumour p-STAT3 binary (positive vs. negative) 0.66 (0.44–0.98) 0.04 0.70 (0.43–1.15) 0.16
 Stroma p-STAT3 ordinala 0.86 (0.67–1.09) 0.20 0.92 (0.68–1.22) 0.55
 Stroma p-STAT3 binary (positive vs. negative) 0.75 (0.52–1.09) 0.13 0.82 (0.52–1.30) 0.39
ER+/HER2+
 Tumor p-STAT3 ordinala 1.09 (0.66–1.80) 0.73 0.86 (0.40–1.85) 0.71
 Tumor p-STAT3 binary (positive vs. negative) 1.33 (0.56–3.21) 0.52 1.34 (0.45–3.93) 0.60
 Stroma p-STAT3 ordinala 0.86 (0.49–1.52) 0.61 0.78 (0.36–1.67) 0.52
 Stroma p-STAT3 binary (positive vs. negative) 0.93 (0.41–2.12) 0.86 0.79 (0.27–2.34) 0.67
a

Ordinal indicates 4 categories for immunohistochemistry, i.e., 0, 0.1–10, 10.1–100, >100; bold font indicates statistical significance. p-STAT3, phosphorylated-signal transducer and activator of transcription 3; ER, estrogen receptor; DFS, disease-free survival; OS, overall survival.